Optimize Melanoma Clinical Trial Management with Biorasi
Established in the early 1970s, clinical research for the treatment of melanoma has continued to expand, with innovative therapies making a positive impact on this often-lethal type of skin cancer. In order to move these trials forward, it is imperative that sponsors develop strategies beyond their clinical protocols to address the multitude of unique characteristics that define each skin cancer study:
- Patient subject criteria and enrollment strategy
- Management of trial milestones and potential challenges to completion
- Usage of remote solutions for patient engagement and study monitoring
- Data capture, analysis, and standardization
- Regulations for conducting trials internationally, if applicable
Biorasi Executes Customized Strategies for Successful Melanoma Studies
At Biorasi, we realize that each melanoma clinical trial is unique – from the subtypes of skin cancer to be studied to the form of treatment or disease management offered. We are a new kind of CRO and are capable of executing all requirements for these trials. We will work with you to determine the best recruitment strategy for your trial, focusing on finding patients that meet your criteria and will participate for the full length of the trial. Our innovative project management solutions are focused on keeping your trials on track and anticipating any potential delays.
We are experienced in decentralized trials and can provide remote solution options to ensure that important milestones are met, and that information is captured and analyzed across multiple data mediums. Additionally, we can expand your trials on a global scale, building stronger patient subject pools that meet trial criteria.